Neuroscience, shipped.
OPTES translates peer-reviewed research into consumer neurotechnology. Our first shipping product, NOVA, delivers Targeted Memory Reactivation during sleep.
The research-to-product gap in neuroscience is structural.
Targeted Memory Reactivation — the mechanism behind sleep-based memory reinforcement — has been peer-reviewed for three decades and replicated across laboratories, cue modalities, and memory types.
- 2007 Rasch et al., Science — olfactory cuing during slow-wave sleep
- 2009 Rudoy et al., Science — auditory cuing of spatial memory
- 2013 Oudiette & Paller — review of targeted reactivation
- 2020 Hu et al. — meta-analysis across 91 experiments
As of 2025, no consumer product ships the mechanism at scale. That is the gap OPTES was founded to close.
Research in, product out.
Every OPTES product follows the same four-step methodology.
-
01
Find the science.
Peer-reviewed, replicated, mechanism understood. Independent replication is the gate — nothing advances without it.
-
02
Engineer the delivery.
Sensors, signal processing, timing, form factor. Research proves what works under polysomnography; a product has to work in a bedroom, every night, at scale.
-
03
Protect the implementation.
Every OPTES product stands on original IP — sensor stacks, ML architectures, delivery mechanisms, timing algorithms. The science is public; the implementation isn't.
-
04
Ship to real people.
Not a medical device. Not a prescription. A consumer product someone chooses to wear — and sees results from.
Starting with sleep.
OPTES ships products one at a time, each fully engineered before the next begins. Our first target is the oldest problem in cognitive science: memory decay overnight.
Nova One headband.
Non-invasive sleep headband delivering Targeted Memory Reactivation. Bone conduction audio, multi-point haptics, on-device ML. Patent-pending architecture.
Active research directions span memory consolidation, attention regulation, and emotional processing during sleep. We'll announce the next product when it's engineered and ready to ship — not before.
The research we build on.
OPTES works across adjacent domains of sleep, memory, and cognitive neuroscience. Every product traces directly to replicated, peer-reviewed findings.
-
01
Targeted Memory Reactivation
Sensory cues replayed during slow-wave sleep selectively strengthen paired memories. Validated in Rasch et al. (2007, Science), Rudoy et al. (2009, Science), Oudiette & Paller (2013), and Hu et al. (2020 meta-analysis). Basis for NOVA.
-
02
Sleep architecture detection
Non-PSG sleep stage classification from PPG, IMU, and temperature data. The constraint: detecting the right sleep phase without an EEG headset. Real-time physiological monitoring at consumer price points.
-
03
Bone conduction audio
Audio delivery below waking threshold via skull-transmitted vibration. Used in Rudoy et al. 2009 and subsequent TMR protocols. Cues memories without disturbing a sleep partner or a bed surface.
-
04
Haptic consolidation cues
Sub-conscious vibration as a cue modality. An active research direction: how tactile stimuli during sleep compare to auditory and olfactory cues — and where haptics outperform both.
Research basis. The retention improvements cited in OPTES materials (20–30%) reflect outcomes from controlled TMR laboratory studies, not real-world consumer trials. OPTES products are not medical devices and have not been evaluated in independent clinical trials.
Built from the science up.
OPTES is a Delaware C-Corp founded in 2025 and headquartered in Denver, Colorado. Solo-founded, patent-pending, and building our first consumer product for 2027 launch.
OPTES exists to close the gap between neuroscience research and consumer neurotechnology — one product at a time, engineered from validated science up.
Read the company story